骨粗鬆症リエゾンサービスと服薬指導

Osteoporosis Liaison Service. Osteoporosis Liaison Service and Medication Instruction.

　骨粗鬆症リエゾンサービスで目指すところは，質の高いより一層充実した骨粗鬆症の予防，診断，治療の提供と，広い社会啓発活動による健康寿命の延伸や健康格差の縮小である。その双方に薬剤師の職能発揮の場面がある。おりしも，平成28年に薬機法に制定された「かかりつけ薬剤師」の制度では，その前者への貢献が求められ，「健康サポート薬局」ではその後者での貢献が求められる。薬剤師も，病院薬剤師と地域の保険薬局薬剤師が双方に服薬情報を提供しあうことによる患者中心の連携体制を構築し臨む必要がある。その意味で，薬剤師の資格を持つ骨粗鬆症マネージャーは連携の肝となることで，自分の地域における骨粗鬆症による骨折の初発防止と再骨折防止に生活面からの支援ができると考えられる。これからのALL薬剤師の連携のつなぎ役として期待したい。

　The goals of the osteoporosis liaison service are to prevent the disease more effectively, to diagnose it properly and to provide a higher quality treatment for it as well as to increase healthy life- span and to minimize the gap in health status by offering raising awareness activities. Pharmacist can play an important role in achieving both of goals. “The family pharmacist system”, which was introduced by the Pharmaceuticals and Medical Devices Law（Yakkiho）in 2016, is expected to contribute to achieve the former goal while “Health supporting pharmacy” is expected to strive for the latter goal. It is also necessary to build a patient-centered collaborative relationship between hospital pharmacists and those of insurance pharmacy by sharing the information on the patients' medication. In that sense, it seems that osteoporosis managers who have a license for a pharmacist can play a significant role as a collaboration hub in the service and they can be expected to help prevent osteoporosis bone fracture and repeated fracture by supporting them in life in the community. It seems their role as a connector among all pharmacists will be more important.